ISSN 1129-2369
Publisher: Springer
< previous issue | all issues | next issue >
Advancing towards a crescendo in 2007 pp. 1-2(2)
Patent foramen ovale and migraine: no reason to intervene pp. 3-6(4) Author: Diener, Hans-Christoph
Migraine, patent foramen ovale and migraine triggers pp. 7-12(6) Authors: Tembl, J.; Lago, A.; Sevilla, T.; Solis, P.; Vilchez, J.
Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans pp. 13-18(6) Authors: Diamond, S.; Freitag, F.; Feoktistov, A.; Nissan, G.
The rare, unilateral headaches. Vågå study of headache epidemiology pp. 19-27(9) Authors: Sjaastad, O.; Bakketeig, L.
Predictors of treatment outcome in headache patients with the Millon Clinical Multiaxial Inventory III (MCMI-III) pp. 28-34(7) Authors: Hansen, J.; Bendtsen, L.; Jensen, R.
Present and previous psychopathology of juvenile onset migraine: a pilot investigation by Child Behavior Checklist pp. 35-42(8) Authors: Salvadori, F.; Gelmi, V.; Muratori, F.
Health-related quality of life among Canadians with migraine pp. 43-48(6) Authors: Brna, P.; Gordon, K.; Dooley, J.
Aspirin and tension-type headache pp. 49-55(7) Authors: Farinelli, I.; Martelletti, P.
Cephalalgiaphobia: a possible specific phobia of illness pp. 56-59(4) Authors: Peres, M.; Mercante, J.; Guendler, V.; Corchs, F.; Bernik, M.; Zukerman, E.; Silberstein, S.
Atypical primary headache responding to finger pressure: possible involvement of the vagus nerve? pp. 60-62(3) Authors: Stani, F.; Calabresi, M.; Pappagallo, M.; Scattoni, L.; Bruti, G.; Cerbo, R.
Lessons from placebo effects in migraine treatment pp. 63-66(4) Authors: Antonaci, F.; Chimento, P.; Diener, H.-C.; Sances, G.; Bono, G.
Temporary pacemaker in refractory cluster headache treated with verapamil pp. 67-68(2) Authors: Perciaccante, A.; Fiorentini, A.; Mitrevski, M.; Tubani, L.; Granata, M.